This Viewpoint reviews potential adverse consequences of US state and insurer policy initiatives to limit opioid prescription duration for patients with acute pain and proposes that condition-specific prescribing guidelines and patient-centered approaches could maintain pain control while reducing the risk of diversion and misuse.
